首页> 中文期刊> 《淮海医药》 >直接测序法与荧光定量PCR法检测非小细胞肺癌EGFR基因突变对比分析

直接测序法与荧光定量PCR法检测非小细胞肺癌EGFR基因突变对比分析

         

摘要

目的:比较直接测序和荧光定量PCR法检测非小细胞肺癌( NSCLC) EGFR基因突变状态结果的差异。方法:分别采用荧光定量PCR(蝎形探针扩增阻滞突变系统ARMS)和直接测序法检测155例石蜡包埋NSCLC样本中EGFR基因18,19,20,21号外显子突变状态,比较检测结果的差异。结果:80例手术切除样本中,直接测序检测EGFR突变阳性者25例(31.25%), ARMS法为28例(35%),差异无统计学意义(P>0.05);75例活检样本中,直接测序检测EGFR突变阳性者19例(25.33%), ARMS法为26例(34.67%),差异具有统计学意义(P<0.05)。结论:对于手术切除样本,直接测序和ARMS法均可有效检测出EGFR基因突变状态;但对于活检组织样本,ARMS较直接测序灵敏性更高。%Objective:To compare the differences between fluorescence quantitative PCR and direct sequencing of detecting EGFR mutations in non-small cell lung cancer.Methods:Both direct sequencing and fluorescence quantitative PCR ( amplification refractory mutation system, ARMS) were used to detect EGFR mutations in exon 18, 19, 20, and 21 in 155 formalin-fixed and parrffin-embeded ( FFPE) NSCLC specimens,and the differences between the two methods were analyzed.Results:In 80 surgical excision samples, EG-FR mutations were identified in 25 cases with a mutation rate of 31.5%by direct sequencing, and in 28 cases with a mutation rate of 35%by ARMS, showing no statistical differences in the two detections(P>0.05).In 75 biopsy specimens, EGFR mutations were i-dentified in 19 cases with a mutation rate of 25.33% by direct sequencing, while in 26 cases with a mutation rate of 34.67% by ARMS.There were significant differences of EGFR mutation rate between the two methods(P<0.05).Conclusion:Both direct se-quencing and ARMS can effectively identify EGFR mutation in surgical excision samples, but in biopsy specimens, ARMS gains a higher sensitivity than direct sequencing in detection of EGFR mutation.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号